Jordan News Updatesأبلغتنا شركة سيجين إنك Seegene Inc. بأنه يتوجب على الصحفيين والقراء الآخرين تجاهل البيان الصحفي، “سيجين توقع اتفاقية تزويد حصرية مع الحكومة الكويتية”، الذي صدر يوم 18 مايو 2021 من خلال PR Newswire. }توقيت التوزيع كان خاطئا (كان يجب توزيع البيان بعد أسبوع){
MILWAUKEE, Wis., May 25, 2021 (GLOBE NEWSWIRE) — WHR Group, Inc. (WHR), a leader in the global employee relocation industry, conducted a Global Mobility Benchmark study surveying some of the largest U.S. companies from a variety of industries. Findings shed light on how companies have changed their employee relocation policies, even during 2020 and a pandemic. Respondents included corporate staff working in HR, mobility management; talent management; and benefits and compensation departments. Some findings include the following:
Over 57% surveyed have an international relocation program, and 88% have expatriate or international permanent transfer policies. Over 50% found immigration laws to be the most challenging part of international relocations with Africa and Asia reported as the most challenging. For Africa, immigration laws and political climate were reported as creating the greatest challenges. For Asia, immigration laws and language barrier created the greatest challenges. Temporary housing; destination services and settling in; household goods; Visa and immigration assistance; and tax assistance are considered core benefits for international transfers and assignments.
Of the 68.5% offering destination closing costs, 76.5% don’t cap this benefit, even though capping the support is a way to control organizational costs. Most companies reported creating benefit packages based on the average transferee, not always considering individual cultures and family dynamics. This can lead to policy exception requests by employees.
Download WHR’s Complete Benchmark Report.
About WHR Group, Inc.
WHR is a privately owned, client-driven global employee relocation management company distinguished by best-in-class service delivery and cutting-edge, proprietary technology. WHR has offices in Milwaukee, Wis., Switzerland, and Singapore. With its 100% client retention rate for the past decade, WHR continues to position itself as the trusted provider in global employee relocation. http://www.whrg.com, LinkedIn
Media Contact: Mindy Stroiman, Corporate Writer
Mindy.Stroiman@whrg.com
262-523-7510
Results of Split-Face Study to Determine the Efficacy and Safety of 2.5% Agarose Gel Filler for the Correction of Nasolabial Folds Published in Peer Reviewed Journal
BROOKLINE, Mass., May 25, 2021 /PRNewswire/ — Advanced Aesthetic Technologies, Inc. (AAT), a leader in aesthetic gel implant technology, is proud to announce that Algeness® VL (2.5% Agarose Gel) demonstrated equivalent efficacy, safety, and usability compared to those of NASHA-L based on a split-face study published in the Journal of Cosmetic Dermatology.
“Agarose gel filler is a naturally occurring polymer gel with a three-dimensional structure similar to the extracellular matrix, which achieves its duration without the need for crosslinking. Our objective with this study of 66 patients was to determine the efficacy and safety of 2.5% agarose gel filler for the correction of nasolabial folds as compared with NASHA-L. Our assessments included assessment of the nasolabial fold (NLF), Wrinkle Severity Rating Scale (WSRS), Global Aesthetic Improvement Scale (GAIS [blinded investigator]), as well as subject satisfaction, adverse events, and usability,” according to lead investigator Nicolò Scuderi MD of the Department of General and Plastic Surgery at the University of La Sapienza, Rome, Italy.
Among the 66 participants in the study, 46 individuals or 66.7% were available for evaluation at 3 months, when mean change in WSRS was identical for both products (−1.1 ± 0.4 for 2.5% agarose; −1.1 ± 0.4 for NASHA-L). Scores for each product remained similar across all time points and began to return to baseline between 7 and 8 months. GAIS score followed a similar pattern, rising between months 7 and 8 (2.7 ± 0.6 for 2.5% agarose at month 7 and 3.3 ± 0.5 at month 8, vs. 2.7 ± 0.6 for NASHA-L at month 7-3.3 ± 0.5 at month 8). The longevity of both fillers was confirmed by Ultrasound. All adverse events were transient in nature and resolved within 15 days, most events were mild in nature, and the number and severity of events was similar between the two fillers. According to Dr. Scuderi, “We continue to be impressed with the clinical outcomes of the novel Algeness® range of dermal fillers. This is the first 100% natural, biocompatible and biodegradable filler on the market to date, which differentiates it from other injectable products.”
U.S. based investigator Brian Kinney, MD, FACS, Division of Plastic Surgery, University of Southern California, Keck School of Medicine, in Beverly Hills, CA, adds, “These results add to the growing body of evidence that confirms that Algeness® (2.5% agarose gel filler) has a high safety profile and is well tolerated by patients. We concluded that this unique dermal filler compound had a longevity which was equivalent to one of the most widely used fillers, NASHA-L a hyaluronic acid.”
Doug Abel, CEO of AAT commented, “We are very pleased with the outcome of this important study which demonstrate that in this initial clinical study, the results with 2.5% agarose gel are equivalent to those of NASHA-L. This is another significant milestone demonstrating the efficacy and performance of our proprietary Algeness® technology. This notable recognition from three internationally respected plastic surgeons reconfirms the durability of the Algeness® technology and secures its place as a differentiator in the global dermal filler market. We have begun the process to pursue both US FDA approval for Algeness® and, through our strategic Partner, registration in China.”
Algeness® is a patented family of fully resorbable injectable gel implant dermal fillers that are 100% natural, providing advantages in terms of safety, skin rejuvenation, and natural looking results both at rest and during facial movement. Typical clinical advantages include minimal swelling upon injection and immediately visible results. Algeness® holds a CE Mark and is currently distributed in over 30 countries worldwide.
About Advanced Aesthetic Technologies, Inc.
AAT is a fast growing, global corporation developing new technologies for aesthetic medicine. Our lead products, the Algeness® family of injectable implants, are the culmination of more than 10 years of scientific and clinical research and were developed with the goal of providing aesthetic injectors advances in the ability to achieve deep structural support, clean definition, and exceptional clinical outcomes where the result at the time of treatment is the final outcome. Algeness® is a 100% natural and biodegradable filler based on purified agarose with a differentiated clinical and safety performance profile. AAT continuously invests in research and product development to expand the scientific knowledge on Algeness® and agarose as well as in pursuit of new and innovative technologies to enhance aesthetic medicine and expand our portfolio. Algeness® is CE Marked, has multiple additional country level registrations, and is currently available in over 30 countries. AAT is in the process of pursuing registration in the US through the FDA and also in China through the partnership with Lanzhou Biotechnique Development Co., LTD (Lanzhou) and their parent company China National Biotec Group Co., LTD (CNBG). http://www.algeness.com
References
Scuderi N, Fanelli B, Fino P, Kinney BM. Comparison of 2.5% agarose gel vs hyaluronic acid filler, for the correction of moderate to severe nasolabial folds. J Cosmet Dermatol. 2021;00:1– 8. https://doi.org/10.1111/jocd.
Contact: filler@algeness.com
Logo – https://mma.prnewswire.com/
Rancho Santa Margarita, Calif., May 25, 2021 (GLOBE NEWSWIRE) — Blue California’s Taxifolin BC-DHQ® with super antioxidant and anti-inflammatory properties is now Generally Recognized As Safe (GRAS) in a range of foods and beverages following a letter of no objection from the US Food and Drug Administration (FDA).
Naturally found in a variety of fruits and vegetables, Dihydroquercetin (DHQ), also known as taxifolin, is a flavonoid commonly found in apples, olive oil and red onions. As a flavonoid, taxifolin possesses powerful antioxidant and anti-inflammatory properties that may support immune health.
“This GRAS status is good news for consumers and brands alike, because it opens new doors for brands to create products that will excite health-conscious consumers,” said Dr. Linda May-Zhang, research, science and innovation officer at Blue California. “DHQ is a powerful antioxidant that has a greater antioxidant capacity when compared to vitamin C, and it is ideal in a variety of on-trend food applications, including beverages, yogurt and chocolate products.”
Health-conscious consumers are actively exploring new functional food and beverages for supporting immune health and wellness. Immune health will remain a top priority for consumers as 64% of global consumers are looking to improve their immunity over the next 12 months, reported by FMCG Gurus, Top Ten Trends for 2021, Dec. 2020.
DHQ seeks and neutralizes free radicals in the body, and its unique molecular structure makes it especially effective at preventing cellular damage. It can also play an important role in skin health since it protects cells and stimulates collagen and elastin production in the skin.
“Taxifolin BC-DHQ has much to offer as a powerful antioxidant in food and beverages as it provides improved color stability for beverages, extends shelf life, and enhances flavor,” said May-Zhang. “Not only is DHQ regarded as a promising ingredient to immune health, it may also be used in cosmetic applications for anti-aging and UV-protection.”
Blue California offers food and beverage manufacturers its high purity Taxifolin BC-DHQ made by a sustainable process. Innovation partner Conagen developed a clean, reliable, and scalable DHQ using its proprietary bioconversion process, resulting in a sustainable production method.
“Conagen is unlocking novel compounds from nature which are more sustainable and offer better options for ingredient applications, said Dr. Casey Lippmeier, vice president of innovation at Conagen. “Our ability to rapidly scale-up and commercialize this and other novel ingredient solutions demonstrates our strength as a strategic service partner.”
Taxifolin BC-DHQ,® is a registered trademark of Blue California, Inc.
Blue California is an entrepreneurial, science-based solutions provider and manufacturer of clean, natural, and sustainable ingredients used in food, beverage, flavor, fragrance, dietary supplements, personal care and cosmetic products. For more than 25 years, Blue California has built a strong reputation for creating value in these diverse natural product and nature-inspired industries.
Conagen is making the impossible possible. Our scientists and engineers use the latest synthetic biology tools to develop sustainable, nature-based molecules bio-manufactured into the highest quality products available. We focus on the bioproduction of high-value ingredients for food, nutrition, flavors and fragrances, pharmaceutical, and renewable materials industries. For more information, visit www.conagen.com
Attachment
Ana Arakelian Blue California ingredients +1-949-635-1991 ana@bluecal-ingredients.com
BEIJING, May 25, 2021 /PRNewswire/ — A news report by China.org.cn on Yuan Longping:
On May 22, Yuan Longping, the renowned Chinese scientist who helped lift countless people out of hunger, passed away, setting off an outpouring of grief among the Chinese public. His passing was reported by numerous foreign media outlets.
Dubbed the “father of hybrid rice,” Yuan Longping cultivated the world’s first high-yielding hybrid rice strain in 1973. Ever since, the yield of hybrid rice has continued to set new world records, from 300 kg to 500 kg and then 700 kg per mu (about 0.07 hectares). Now, the per-mu yield of the super hybrid rice Chaoyou 1000 developed by Yuan’s team has exceeded 1,000 kg. Before Yuan, the world’s scientific community believed that rice could not be crossbred.
This ordinary but great man not only helped China, a country with a population of 1.4 billion, solve the problem of achieving food self-sufficiency, but also made important contributions to global food security.
At present, the hybrid rice developed by Yuan’s team has been introduced for wide application and trial planting in dozens of countries and regions around the world. In Madagascar, the yields from hybrid rice were up to 300% higher than those of native varieties. In Indonesia, they produced more than double that of local strains. In 2018, trials for growing rice in the deserts of Dubai were, for the first time in history, successfully carried out by Yuan’s team.
In many people’s eyes, he was a scientist who relentlessly pursued his dreams despite loneliness and hardship. Hybrid breeding experiments are no easy tasks. In the early days of his research, Yuan personally examined more than 14,000 rice ears before he found six natural male sterile plants. At the age of 90, he was still out conducting research, visiting the fields almost every day to observe the growth of hybrid rice.
Yuan was also a benevolent gentleman with an unwavering commitment to the well-being of humanity. Though born into a well-educated family, he witnessed starvation when he was young, which made him determined to devote himself to agricultural research. He spent more than 10 years helping African countries grow hybrid rice and worked tirelessly to tap the yield potential of rice for decades. During the last few years of his life, Yuan was dedicated to the research and development of sea rice. He made every effort to fulfill his lifelong wish — people all over the world having enough to eat.
Yuan Longping has left behind a precious legacy of the little rice seed to the world. “Everyone is like a seed — we should try to grow into good people,” Yuan once said. This ordinary but great man is worth remembering.
China Mosaic
http://www.china.org.cn/video/
Yuan Longping: Committed to benevolence and humanity’s well-being
http://www.china.org.cn/video/
Video – https://mma.prnewswire.com/
سيؤول، كوريا الجنوبية، 25 أيار/مايو 2021 / PRNewswire / — أعلنت شركة سيغين Seegene Inc. (KQ 096530)، وهي شركة تشخيص جزيئي، عن نتائجها المالية للربع الأول من العام 2021، بتقارير تظهر أرباحًا قوية للشركة. وسجلت شركة التكنولوجيا الحيوية 351.8 مليار وون كوري على هيئة إيرادات مجمعة، بزيادة قدرها 330% مقارنة بالفترة نفسها من العام الماضي، وهو رقم قياسي للربع الأول. وبلغت الأرباح التشغيلية 193.9 مليار وون كوري، بزيادة 388% على أساس سنوي، ما يعكس نموًا ثابتًا في مبيعاتها من الاختبارات التشخيصية.
وقال ميونغكون كيم، المدير الإداري الأول لقسم العلاقات الدولية والعامة في شركة سيغين: “تمكنت الشركة من إدارة 55% من نسبة أرباح التشغيل السنوية، وهو ما يعكس بوضوح قدرتها على إدارة الشركة بفعالية على الرغم من الاستثمار المستمر في البحث والتطوير وتوسيع القوى العاملة.” وأضاف أنه “بمجرد أن تؤتي الاستثمارات ثمارها، فمن المرجح أن ترتفع نسبة الربح التشغيلي أكثر من ذلك”.
وأضاف كيم أن “أداء سيغين القوي كان مدعومًا بالزيادة المستمرة في الطلب على الاختبارات التشخيصية لتحورات فيروس كوروناالمستجد، ومع عودة المزيد من الحكومات في جميع أنحاء العالم إلى الحياة الطبيعية من خلال الاختبارات الجماعية في المدارس وأماكن العمل.” وقال إنه من المتوقع أن تشهد الشركة زيادة إضافية في المبيعات من خلال دخول أسواق جديدة بالإضافة إلى إطلاق منتجات وتقنيات جديدة. وأضاف كيم أنه “على الرغم من أنه من المتوقع أن يُظهر الربع الثاني حجم مبيعات مشابهًا لحجم مبيعات الربع الأول، إلا أن النصف الأخير من العام يبدو واعدًا أكثر بسبب التأخير في صفقات التوريد التي تنعكس على أرقام المبيعات الفعلية.”
أمنت شركة سيغين سابقًا صفقة مشتريات عامة لاختبارات تشخيص كوفيد-19 في إيطاليا بقيمة تزيد عن 89.3 مليون يورو، واتفاقية مناقصة عامة منفصلة في اسكتلندا بقيمة 16,209,150 جنيهًا إسترلينيًا وصفقة بيع لألمانيا بقيمة 19.3 مليون يورو.
لشعار – https://mma.prnewswire.com/
SEOUL, South Korea, May 25, 2021 /PRNewswire/ — Seegene Inc. (KQ 096530), a molecular diagnostics company reported its financial results for the first quarter of 2021, with reports showing robust earnings. The biotechnology firm posted KRW 351.8 billion in consolidated revenue, a 330% increase compared to the same period last year and a record for the first quarter. Operating profit at KRW 193.9 billion, also up 388% on-year, reflecting steady growth in its sales of diagnostic tests.
Seegene’s Senior Managing Director of IR and PR Department Myungkun Kim said “the company was able to manage 55% of annual operating profit ratio, a clear reflection of its ability to effectively manage the firm despite the constant investment in R&D and expansion of manpower.” He added that “once investments come to fruition, the operating profit ratio will likely surge even further.”
Kim added “Seegene’s thriving performance had been backed with continuous surge in demand for variant diagnostic tests and as more governments around the world are reeling back to normalcy with mass examinations at schools and workplaces.” He said the company is expected to see additional surge in sales through entering new markets as well as launching new products and technologies.” The head of IR and PR Dept. added that “although the second quarter is predicted to show comparable sales volume to that of the first quarter, due to a delay in supply deals being reflected onto actual sales figures, the latter half of the year however looks even more promising.”
Seegene had previously secured public procurement for COVID-19 diagnostic tests in Italy worth over EUR 89.3 million, a separate public tender agreement in Scotland worth 16,209,150 GBP and a supply deal in Germany worth EUR 19.3 million.
Logo – https://mma.prnewswire.com/
BANGKOK, May 25, 2021 /PRNewswire/ — Electrolux, a Swedish progressive and premium home life brand, invites young people across Asia Pacific, Middle East and Africa to join forces with the company’s team of experts and some of the most influential change-makers of today to explore solutions for future sustainable homes. The call to action, titled “Better Living in 2030”, aims to learn more about young people’s hopes, dreams and concerns, so Electrolux can work alongside the team to respond with solutions tailored to young people’s daily living needs in the next decade to come.
As a part of realizing the company’s vision and bold 2030 targets for better and more sustainable living around the world, Electrolux invites today’s youth to join a team change-makers – a collaboration between Electrolux, young minds from across the globe wanting to drive positive change, and leading change-makers and experts already making a difference today. Together with the company’s innovation hub, the team will explore solutions for better living, starting with the future for clothes and garment care.
By seeking insights from the very people who will be setting up their own homes within a decade’s time, Electrolux believes it will be better positioned to provide solutions that live up to the company purpose, Shape living for the better, for generations to come.
“We want to listen to those who will be starting up their own homes in the near future. What are their hopes and dreams when they think about their lives ten years from now? Their desires, choices and behaviors will play a critical role in shaping the evolution of better living. We want those who own the future to be part of defining it. Therefore, we take the opportunity to ask now – to be able to provide solutions tailored to their needs, come 2030,” says Jonas Samuelson, CEO Electrolux.
In the open letter, signed by CEO Jonas Samuelson, Electrolux invites young people between the ages of 15 and 20 across the globe to join the change-maker team. The young people selected will then be accompanied by some of today’s most influential change-makers to help explore solutions for better living in 2030.
As part of the same initiative, Electrolux will conduct a global survey in which almost 14,000 young people between the ages 15 to 20 will be asked about how they envision their future sustainable homes. Insights from the survey and the sessions with the change-makers will be used by Electrolux in its strive to create new innovations for a better living.
The initiative is part of Electrolux’s ambitious Better Living Program. With bold targets for 2030 focusing on better eating, better garment care, better home environment, and better company, the initiative widens the scope of Electrolux’s commitment to sustainability. It enables the company to contribute in a more meaningful way in bringing solutions to global challenges.
Read more about the team of change-makers and how to apply at http://www.
Click the link below for video
https://youtu.be/i_4v90pB_E4
Electrolux is a leading global appliance company that has shaped living for the better for more than 100 years. We reinvent taste, care and wellbeing experiences for millions of people, always striving to be at the forefront of sustainability in society through our solutions and operations. Under our brands, including Electrolux, AEG and Frigidaire, we sell approximately 60 million household products in approximately 120 markets every year. In 2020 Electrolux had sales of SEK 116 billion and employed 48,000 people around the world. For more information go to www.electroluxgroup.com.
Photo – https://mma.prnewswire.com/
BEIJING, May 25, 2021 /PRNewswire/ — A news report by China.org.cn on US politicization of tech supply chains is both risky and costly.
In 2019, the Trump administration unleashed its “tech war” on China, with the goal of blocking China’s development in high tech sectors by preventing targeted companies from procuring components manufactured in the United States.
As the White House ramped up its hostility toward Beijing, it intensified its measures. The most notable target was the Chinese telecommunications firm Huawei, which was first placed on the commerce department’s “entity list” putting it under export controls. Later, it was also subjected to the “foreign direct product rule,” which unilaterally banned overseas companies who use U.S. patents in their own semiconductor production from supplying the company.
![A staff member works at a workshop of a semiconductor company in Shanghai, east China, Feb. 10, 2020. [Photo/Xinhua]](https://mma.prnewswire.com/media/1517521/image1.jpg "A staff member works at a workshop of a semiconductor company in Shanghai, east China, Feb. 10, 2020. [Photo/Xinhua]")
Even though President Joe Biden has since taken office, he has yet to reverse these decisions. Instead, he has pressed on in the mold of an “America First” policy when it comes to semiconductors with the goal of consolidating a U.S. monopoly of the industry and controlling “technologies of the future.”
What have been the consequences of these decisions? In fact, they have had adverse effects for America and the world at large.
The aggressive politicization of the semiconductor sector against the world’s second largest economy is disrupting a global supply chain, reversing globalization and creating an effect of “localization.”
China has massively boosted its investment in semiconductor capabilities on a whole-of-society scale, while America has created political risks for tech firms who rely on their supplies. On an organizational level, firms have been bulk buying semiconductor and lithography manufacturing equipment from the Netherlands, Japan and South Korea, as well as panic buying semiconductors to hedge against potential future restrictions. Companies are losing confidence in traditional suppliers.
This uncertainty has created a global shortage in semiconductors, which is causing risks to the global economy. The shortage has created delays in the manufacturing and supply of electronic consumer goods and automobiles, which has forced many factories around the world to postpone production and furlough workers. For example, Nissan’s Sunderland factory in the U.K. was forced to slow production for three weeks due to a lack of semiconductors. Another consequence has been growing inflation, which undoubtedly contributed to the unexpected surge in the U.S. consumer price index, which jittered global markets last week.
These adverse outcomes show that weaponizing technology supply chains against China will not make America better off. Localized supply chains are more expensive and will cost the U.S. considerable market share as Beijing develops its own industry. This year, China will commence production of 7-nanometer nodes and quickly cede dependency on lower nodes, with Semiconductor Manufacturing International Corporation (SMIC) investing in a $2.35 billion chip foundry in Shenzhen set to produce 28-nm integrated circuits. This has allowed companies such as Huawei to continue developing their 5G networks despite U.S. sanctions.
In China, government investment in the sector has already amounted to $150 billion, while earmarked investment for the 14th Five-Year Plan period (2021-25) extends to $1 trillion. While this is seen as a political necessity, few disagree that an open-ended global industry remains preferential. Leading foreign semiconductor companies still seek to compete within the Chinese semiconductor market due to its growing economy and surging demand, showing the dangers of upheaving this market.
In this case, it is worth noting that one thing is certain when it comes to current U.S. policy: Weaponizing semiconductors creates a “lose-lose” situation, carving up a global industry into localized spheres, creating a fractured market and raising prices. That being said, it will still not block China’s technological advances.
For all involved, it is a costly and unpredictable path with knock on effects all the way down to the ordinary consumer.
Tom Fowdy is a British political and international relations analyst and a graduate of Durham and Oxford universities. He writes on topics pertaining to China, the DPRK, Britain and the U.S. For more information please visit: http://www.china.org.cn/
Opinion articles reflect the views of their authors, not necessarily those of China.org.cn.
If you would like to contribute, please contact us at opinion@china.org.cn.
Ongoing work with client TYM and expanding market demand results in dedicated Asian presence
NEW YORK, May 25, 2021 /PRNewswire/ — MBLM (pronounced Emblem), the Brand Intimacy Agency focused on building ultimate brand relationships using emotional science, is proud to announce the opening of a new office in Seoul, Korea. This marks MBLM’s first Asian location and its strategic expansion into new markets.
The seasoned team is being led by managing director Nelson Hur. He brings a unique perspective, having worked for over 20 years in the industry for multiple agencies where he served large Korean companies, including Cheil Worldwide and Samsung. Hur supports a strong executive team with expertise across a broad range of industries including consumer goods, technology, financial services, industrial and retail.
“Our executive team is excited to be leading MBLM’s Korean expansion,” says Hur. “MBLM’s proficiency across both brand and digital capabilities, combined with the firm’s Brand Intimacy focus, creates a compelling proposition for Korean brands looking to grow, prosper and expand beyond Korea.”
The Korea office recently rebranded TYM, a leading manufacturer of premium compact and utility tractors, and continues to oversee its branding and marketing needs.
William Shintani, managing partner at MBLM, notes, “We spent a considerable amount of time cultivating our Korean presence, ensuring we had the best team to represent MBLM with the ability to deliver unparalleled services and tools for our clients.”
With its expansion into Korea, MBLM continues to grow its global footprint and now has offices in five countries located in the U.S., Mexico, Canada, the UAE and South Korea. The Korea office will work on brands in Asia, looking to enhance their local presence or expand to overseas markets. The team will also support MBLM’s global clients, utilizing the team’s Asian footprint. They already have a mix of B2B and B2C brands and are looking forward to conducting, analyzing and publishing the Korean edition of MBLM’s annual Brand Intimacy Study.
About MBLM: MBLM has invented a new marketing paradigm, Brand Intimacy, delivering expertise and offerings across three areas of focus: Agency, Lab and Platform. With offices in five countries, our multidisciplinary teams help clients build stronger bonds and deliver optimized marketing outcomes and returns for the long term. To learn more about how we can help you create and sustain ultimate brand relationships, visit mblm.com.
Photo – https://mma.prnewswire.com/
Logo – https://mma.prnewswire.com/
